Acerus Pharmaceuticals Corporation ASPCF
Set alert
As of Jan 12, 9:53 AM ET
- Open
- 0.21988
- Prev close
- 0.21988
- Mkt cap
- 0
- Vol
- 500
- Avg vol
- 69
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.21988
- High
- 0.21988
- Earnings
- Mar 13, 2023
News
6 months ago defenseworld.net
China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison
Volatility and Risk Acerus Pharmaceuticals has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, China Pharma has a beta of 1.08, meaning that its…
11 months ago defenseworld.net
Critical Review: Acerus Pharmaceuticals (OTCMKTS:ASPCF) vs. Zymeworks (NASDAQ:ZYME)
Acerus Pharmaceuticals (OTCMKTS:ASPCF - Get Free Report) and Zymeworks (NASDAQ: ZYME - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the…
3 years ago globenewswire.com
Acerus Update
TORONTO, July 10, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company”) announces that, in connection with its creditor protection proceedings under the Companies' Creditors…
4 years ago seekingalpha.com
Acerus Pharmaceuticals Corporation (ASPCF) CEO Edward Gudaitis on Q2 2022 Results - Earnings Call Transcript
Acerus Pharmaceuticals Corporation (OTCQB:ASPCF) Q2 2022 Earnings Conference Call August 9, 2022 10:00 AM ET Company Participants Edward Gudaitis - President & Chief Executive Officer Robert Motz -…
4 years ago globenewswire.com
Acerus to Report Q2-2022 Financial Results and Host Investor Call
TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2022 financial and operating results on Tuesday, August 9, 2022…
4 years ago globenewswire.com
Acerus To Report Q4 And Full Year 2021 Financial Results And Host Investor Call
TORONTO, March 10, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its fourth quarter and full year 2021 financial and operating results on Tuesday,…
4 years ago seekingalpha.com
Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q3 2021 Results - Earnings Call Transcript
Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q3 2021 Results - Earnings Call Transcript
4 years ago globenewswire.com
Acerus to Report Q3-2021 Financial Results and Host Investor Call
TORONTO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its third quarter 2021 financial and operating results on Tuesday, November 9, 2021…
5 years ago globenewswire.com
Acerus Announces Participation in HC Wainwright Conference
TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today announced that it will participate in the H.C. Wainwright 23rd…
5 years ago globenewswire.com
Acerus Reports Acceptance of Part 36 Settlement Offer in Recipharm Litigation
TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today announced that it had accepted a Part 36 settlement offer made…
5 years ago seekingalpha.com
Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q2 2021 Results - Earnings Call Transcript
Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q2 2021 Results - Earnings Call Transcript
5 years ago globenewswire.com
Acerus Reports Fiscal 2021 Second Quarter Financial Results
Revenue Triples after Buyback of US Rights for NATESTO® Revenue Triples after Buyback of US Rights for NATESTO®
5 years ago globenewswire.com
Acerus to Report Q2-2021 Financial Results and Host Investor Call
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2021 financial and operating results on Tuesday, August 10, 2021…
5 years ago globenewswire.com
Acerus Provides Update on Litigation with Recipharm
TORONTO, July 12, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP, OTCQB:ASPCF) today announced that, on June 15, 2021, it prevailed at a preliminary…
5 years ago globenewswire.com
Acerus Announces New PBM Contract, Significantly Expanding NATESTO® Insurance Coverage in the United States
NATESTO® Coverage now Includes 85% of Commercial Lives NATESTO® Coverage now Includes 85% of Commercial Lives
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday